MEI Pharma announces $100M PIPE deal to add Litecoin to corporate treasury

MEI Pharma announced Friday a $100 million private investment in public equity (PIPE) transaction to add Litecoin into its corporate treasury. The announcement is the first known instance of a publicly traded biotech company adopting Litecoin (LTC) as its primary reserve asset. Per a press statement published at 13:00 BTS, the investment round was led […]

Source: cryptopolitan.com (Read Full Article)